MA47287A - Polypeptides antigéniques de la grippe modifiés et compositions immunogènes correspondantes - Google Patents
Polypeptides antigéniques de la grippe modifiés et compositions immunogènes correspondantesInfo
- Publication number
- MA47287A MA47287A MA047287A MA47287A MA47287A MA 47287 A MA47287 A MA 47287A MA 047287 A MA047287 A MA 047287A MA 47287 A MA47287 A MA 47287A MA 47287 A MA47287 A MA 47287A
- Authority
- MA
- Morocco
- Prior art keywords
- influenzatigenic
- polypeptides
- modified
- immunogenic compositions
- corresponding immunogenic
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16061—Methods of inactivation or attenuation
- C12N2760/16062—Methods of inactivation or attenuation by genetic engineering
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562169814P | 2015-06-02 | 2015-06-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA47287A true MA47287A (fr) | 2019-11-27 |
Family
ID=61521273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA047287A MA47287A (fr) | 2015-06-02 | 2016-06-02 | Polypeptides antigéniques de la grippe modifiés et compositions immunogènes correspondantes |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP3303368A2 (fr) |
| MA (1) | MA47287A (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016196846A2 (fr) | 2015-06-02 | 2016-12-08 | Sanofi Pasteur Inc. | Polypeptides antigéniques de la grippe modifiés et compositions immunogènes correspondantes |
| AU2017272344B2 (en) | 2016-06-02 | 2022-03-03 | Sanofi Pasteur Inc. | Engineered influenza antigenic polypeptides and immunogenic compositions thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140286981A1 (en) * | 2013-03-14 | 2014-09-25 | Wisconsin Alumni Research Foundation | Broadly reactive mosaic peptide for influenza vaccine |
-
2016
- 2016-06-02 EP EP16732382.3A patent/EP3303368A2/fr active Pending
- 2016-06-02 MA MA047287A patent/MA47287A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3303368A2 (fr) | 2018-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3563863A4 (fr) | Préparation lyophilisée | |
| EP3513809A4 (fr) | Composition médicinale | |
| EP3493800A4 (fr) | Composition decannabis | |
| DK3529248T3 (da) | Farmaceutiske sammensætninger | |
| DK3655017T3 (da) | Farmaceutisk sammensætning | |
| EP3339331A4 (fr) | Composition | |
| EP3398996A4 (fr) | Composition | |
| EP3334726A4 (fr) | Compositions de plinabuline | |
| BR112018000054A2 (pt) | composições farmacêuticas liofilizadas | |
| DK3528902T3 (da) | Ringegelsammensætning | |
| EP3430073A4 (fr) | Composition de polyaryléthercétone | |
| EP3560512A4 (fr) | Composition de vaccin contre le zona | |
| EP3395887C0 (fr) | Composition de caoutchouc fluoré | |
| DK3322295T3 (da) | Sammensætning | |
| FI20155191L (fi) | Nivel | |
| EP3480228A4 (fr) | Composition | |
| DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf | |
| DK3583943T3 (da) | Farmaceutisk sammensætning | |
| EP3556804A4 (fr) | Composition | |
| DK3393254T3 (da) | Sammensætning | |
| LT3173071T (lt) | Maropitanto kompozicija | |
| EP3369418A4 (fr) | Composition | |
| MA45165A (fr) | Polypeptides antigéniques de la grippe modifiés et compositions immunogéniques associées | |
| SMT202400478T1 (it) | Composizione farmaceutica | |
| EP3443034C0 (fr) | Composition |